24.47
price down icon2.86%   -0.72
after-market 시간 외 거래: 24.15 -0.32 -1.31%
loading
전일 마감가:
$25.19
열려 있는:
$25.02
하루 거래량:
640.38K
Relative Volume:
0.76
시가총액:
$2.76B
수익:
$14.09M
순이익/손실:
$-176.94M
주가수익비율:
-11.38
EPS:
-2.15
순현금흐름:
$-141.24M
1주 성능:
+0.62%
1개월 성능:
+3.69%
6개월 성능:
+17.03%
1년 성능:
+45.92%
1일 변동 폭
Value
$24.12
$25.03
1주일 범위
Value
$23.68
$25.65
52주 변동 폭
Value
$14.06
$27.29

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name
명칭
Newamsterdam Pharma Company Nv
Name
전화
35 206 2971
Name
주소
GOOIMEER 2-35, NARRDEN
Name
직원
77
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
NAMS's Discussions on Twitter

NAMS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NAMS
Newamsterdam Pharma Company Nv
24.47 2.84B 14.09M -176.94M -141.24M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-17 개시 Goldman Neutral
2025-06-17 개시 Citigroup Buy
2025-06-10 개시 Stifel Buy
2025-06-04 개시 Cantor Fitzgerald Overweight
2024-12-30 개시 H.C. Wainwright Buy
2024-05-15 개시 TD Cowen Buy
2024-03-14 개시 Scotiabank Sector Outperform
2024-01-18 개시 Guggenheim Buy
2024-01-16 개시 Piper Sandler Overweight
2023-10-30 개시 RBC Capital Mkts Outperform
모두보기

Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스

pulisher
Aug 27, 2025

What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Performance Summary & Fast Entry High Yield Tips - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

What to expect from NewAmsterdam Pharma Company N.V. in the next 30 daysPortfolio Value Summary & Stepwise Trade Execution Plans - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

NewAmsterdam announces acceptance of MAA for review by EMA for obicetrapib - MSN

Aug 27, 2025
pulisher
Aug 27, 2025

Predicting NewAmsterdam Pharma Company N.V. trend using moving averagesEarnings Growth Report & Expert Verified Movement Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

What earnings revisions data tells us about NewAmsterdam Pharma Company N.V.Stop Loss & Growth Focused Investment Plans - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Is NewAmsterdam Pharma Company N.V. Equity Warrant a candidate for recovery playQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Price action breakdown for NewAmsterdam Pharma Company N.V. Equity WarrantMarket Growth Summary & Breakout Confirmation Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

How to integrate NewAmsterdam Pharma Company N.V. Equity Warrant into portfolio analysis toolsJuly 2025 Earnings & Reliable Entry Point Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

NewAmsterdam Pharma Company N.V. stock prediction for this weekPortfolio Value Report & Real-Time Volume Analysis Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Historical volatility pattern of NewAmsterdam Pharma Company N.V. visualizedTrade Analysis Report & Daily Growth Stock Investment Tips - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Using Ichimoku Cloud for NewAmsterdam Pharma Company N.V. Equity Warrant technicalsTake Profit & Weekly High Potential Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V. Equity WarrantWeekly Trade Report & Weekly High Potential Stock Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Analyzing NewAmsterdam Pharma Company N.V. with risk reward ratio charts2025 Market Sentiment & AI Optimized Trade Strategies - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Short interest data insights for NewAmsterdam Pharma Company N.V.Index Update & Fast Entry High Yield Stock Tips - Newser

Aug 27, 2025
pulisher
Aug 26, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant stock momentum explained2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Newamsterdam Pharma shares rise 1.86% intraday after insider sold shares. - AInvest

Aug 26, 2025
pulisher
Aug 26, 2025

Momentum divergence signals in NewAmsterdam Pharma Company N.V. chart2025 Market Outlook & Daily Stock Momentum Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Real time breakdown of NewAmsterdam Pharma Company N.V. stock performanceGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Using R and stats models for NewAmsterdam Pharma Company N.V. forecasting2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

What’s the recovery path for long term holders of NewAmsterdam Pharma Company N.V.Weekly Stock Summary & AI Powered Market Entry Ideas - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Comparing NewAmsterdam Pharma Company N.V. Equity Warrant in custom built stock radarsMarket Growth Review & Accurate Technical Buy Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Published on: 2025-08-25 21:09:41 - beatles.ru

Aug 25, 2025
pulisher
Aug 25, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant’s volatility index tracking explainedGlobal Markets & Reliable Intraday Trade Plans - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Full technical analysis of NewAmsterdam Pharma Company N.V. Equity Warrant stockStock Surge & Stock Portfolio Risk Control - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September - GlobeNewswire

Aug 25, 2025
pulisher
Aug 25, 2025

Major Phase 3 Data Coming: NewAmsterdam's Novel Cholesterol Drug Results at ESC Congress 2025 - Stock Titan

Aug 25, 2025
pulisher
Aug 25, 2025

NewAmsterdam Pharma stock initiated at Overweight by Wells Fargo - Investing.com UK

Aug 25, 2025
pulisher
Aug 25, 2025

Can NewAmsterdam Pharma Company N.V. recover in the next quarterJuly 2025 Levels & Safe Capital Investment Plans - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Does NewAmsterdam Pharma Company N.V. qualify in momentum factor screeningMarket Performance Summary & Risk Controlled Swing Alerts - Newser

Aug 25, 2025
pulisher
Aug 24, 2025

Is NewAmsterdam Pharma Company N.V. trending in predictive chart models2025 Investor Takeaways & Safe Capital Growth Plans - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

Smart tools for monitoring NewAmsterdam Pharma Company N.V.’s price action - Newser

Aug 24, 2025
pulisher
Aug 23, 2025

Institutional scanner results for NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Value Report & AI Powered Market Trend Analysis - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

NewAmsterdam Pharma Company N.V. Chart Enters High Volatility ZoneJuly 2025 Setups & Risk Controlled Stock Pick Alerts - beatles.ru

Aug 23, 2025
pulisher
Aug 22, 2025

Short Term Trend Reversal in NewAmsterdam Pharma Company N.V. PossibleJuly 2025 EndofMonth & Expert Verified Stock Movement Alerts - beatles.ru

Aug 22, 2025
pulisher
Aug 22, 2025

CDMO Piramal Pharma Solutions NewAmsterdam Pharma Partner To Expand Oral Solid Dosage Production At Sellersville PA Manufacturing Site - Pharmaceutical Online

Aug 22, 2025
pulisher
Aug 21, 2025

Is NewAmsterdam Pharma Company N.V. Equity Warrant’s ROE strong enoughJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - theviewers.co.kr

Aug 21, 2025
pulisher
Aug 21, 2025

Can NewAmsterdam Pharma Company N.V. Equity Warrant stock double in the next yearPortfolio Update Report & Fast Entry High Yield Stock Tips - theviewers.co.kr

Aug 21, 2025
pulisher
Aug 21, 2025

Piramal, NewAmsterdam Pharma Open Dedicated OSD Form Suite - Contract Pharma

Aug 21, 2025
pulisher
Aug 21, 2025

Visual analytics tools that track NewAmsterdam Pharma Company N.V. performanceJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser

Aug 21, 2025
pulisher
Aug 21, 2025

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - Yahoo Finance

Aug 21, 2025
pulisher
Aug 21, 2025

Published on: 2025-08-20 23:10:07 - Newser

Aug 21, 2025
pulisher
Aug 21, 2025

How to build a dashboard for NewAmsterdam Pharma Company N.V. Equity Warrant stock2025 Macro Impact & Capital Protection Trading Alerts - Newser

Aug 21, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-20 15:56:49 - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

Will NewAmsterdam Pharma Company N.V. price bounce be sustainableJuly 2025 Short Interest & Safe Capital Growth Stock Tips - Newser

Aug 20, 2025

Newamsterdam Pharma Company Nv (NAMS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
자본화:     |  볼륨(24시간):